Search - tctmd.com

Displaying 41 - 60 of 103

Sort: Relevancy | Date

Presentation THT 2025

Duration of Heart Failure, Cardiac Dysfunction and Remodeling, and Response to Atrial Shunt Treatment in HFpEF and HFmrEF

Presenter: Barry Borlaug

February 11, 2025

Presentation THT 2025

Is There a Difference in the Benefits of AF Ablation in HFrEF vs HFpEF?

Presenter: Andrea Russo

February 11, 2025

Presentation THT 2025

Obese HFpEF Patients Exhibit Distinct Augmentation Patterns of VO2 Components During Exercise

Presenter: Takenori Ikoma

February 11, 2025

Presentation THT 2025

How Regulation of Stressed Blood Volume at Rest and Exercise Contributes to HFpEF Symptomatology

Presenter: Sanjiv Shah

February 11, 2025

Presentation THT 2025

Assessing Determinants of Maximal Exercise Tolerance: What Are the Relative Contributions of PCWP, Ventilatory Anaerobic Threshold and Lactate

Presenter: Yogesh Reddy

February 11, 2025

Presentation THT 2025

Setting Pace in HFpEF: The Rationale for Personalized Heart Rates

Presenter: Harriette Van Spall

February 11, 2025

Presentation THT 2025

Insights Into Hemodynamic Mechanisms of HFpEF From Advanced Invasive Hemodynamic Measurements

Presenter: Philipp Lurz

February 11, 2025

Presentation THT 2025

Session Introduction: Novel Frontiers in HFpEF Diagnostics and Management

Presenter: Kavita Sharma

February 11, 2025

Presentation THT 2025

Renal Dysfunction as a Primary Mechanism of Symptoms in (Most) Patients With HFpEF

Presenter: Jeffrey Testani

February 11, 2025

Presentation THT 2025

Comprehensive Mapping of Exercise Hemodynamic Responses and Multi-Organ System Reserve Capacity in HFpEF and Implications for Individualized Management

Presenter: Isabela Landsteiner

February 11, 2025

Presentation THT 2025

Mechanisms by Which Cardiometablic Drugs Help People Feel Better

Presenter: Barry Borlaug

February 11, 2025

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation THT 2024

PH-HFpEF: Levosimendan

Presenter: Sanjiv J. Shah

March 06, 2024

Presentation THT 2024

Imaging in HFpEF Trials: Going Beyond Echocardiography

Presenter: Robert O. Bonow

March 05, 2024

Presentation THT 2024

Heart Failure Solutions: The PeriCut Device as a Treatment for HFpEF

Presenter: Mark Strong

March 05, 2024

Presentation THT 2024

CCM Applied to Patients With HFpEF

Presenter: Javed Butler

March 04, 2024

Presentation THT 2024

Physiological Effects of Renal Denervation in Patients With HFpEF

Presenter: Karl-Philipp Rommel

March 04, 2024

Presentation THT 2024

Pericut: Pericardiotomy as a Therapy for HFpEF

Presenter: Barry Borlaug

March 04, 2024

Presentation THT 2024

Splanchnic Denervation in HFpEF

Presenter: Marat Fudim

March 04, 2024

Presentation THT 2024

Personalized Pacing for HFpEF: myPACE

Presenter: Markus Meyer

March 04, 2024

Advertisement

Duration of Heart Failure, Cardiac Dysfunction and Remodeling, and Response to Atrial Shunt Treatment in HFpEF and HFmrEF

Is There a Difference in the Benefits of AF Ablation in HFrEF vs HFpEF?

Obese HFpEF Patients Exhibit Distinct Augmentation Patterns of VO2 Components During Exercise

How Regulation of Stressed Blood Volume at Rest and Exercise Contributes to HFpEF Symptomatology

Assessing Determinants of Maximal Exercise Tolerance: What Are the Relative Contributions of PCWP, Ventilatory Anaerobic Threshold and Lactate

Setting Pace in HFpEF: The Rationale for Personalized Heart Rates

Insights Into Hemodynamic Mechanisms of HFpEF From Advanced Invasive Hemodynamic Measurements

Session Introduction: Novel Frontiers in HFpEF Diagnostics and Management

Renal Dysfunction as a Primary Mechanism of Symptoms in (Most) Patients With HFpEF

Comprehensive Mapping of Exercise Hemodynamic Responses and Multi-Organ System Reserve Capacity in HFpEF and Implications for Individualized Management

Mechanisms by Which Cardiometablic Drugs Help People Feel Better

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

PH-HFpEF: Levosimendan

Imaging in HFpEF Trials: Going Beyond Echocardiography

Heart Failure Solutions: The PeriCut Device as a Treatment for HFpEF

CCM Applied to Patients With HFpEF

Physiological Effects of Renal Denervation in Patients With HFpEF

Pericut: Pericardiotomy as a Therapy for HFpEF

Splanchnic Denervation in HFpEF

Personalized Pacing for HFpEF: myPACE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content